| Torisel (temsirolimus) / Pfizer |
| Completed | 2 | 12 | Europe | Temsirolimus, Bevacizumab | Rigshospitalet, Denmark, University of Copenhagen, Wyeth is now a wholly owned subsidiary of Pfizer, Roche, Copenhagen | Glioblastoma Multiforme | 02/10 | 02/10 | | |
NCT00494091: Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma |
|
|
| Completed | 2 | 82 | Japan, RoW | Temsirolimus (CCI-779), Torisel | Pfizer | Advanced Renal Cell Carcinoma | 05/11 | 03/12 | | |
|
NCT00417677: A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma |
|
|
| Terminated | 1/2 | 124 | US | Combination of Temsirolimus and Sunitinib | Wyeth is now a wholly owned subsidiary of Pfizer | Renal Cell Carcinoma | | 05/07 | | |
| Withdrawn | 1/2 | 20 | Europe | Temsirolimus, Torisel®, Bendamustine | Charite University, Berlin, Germany, Wyeth is now a wholly owned subsidiary of Pfizer, Mundipharma K.K. | Mantle Cell Lymphoma | 04/12 | 04/14 | | |
NCT00949325: Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma |
|
|
| Completed | 1/2 | 24 | US | temsirolimus plus liposomal doxorubicin, Torisel, Doxil | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Comprehensive Cancer Network, Wyeth is now a wholly owned subsidiary of Pfizer | Sarcoma | 09/12 | 09/12 | | |
|
|
| Completed | 1/2 | 39 | Europe | Temsirolimus, Rituximab, Bendamustin, Mabthera, Rituxan, Torisel, Bendamustin, Ribomustin, Trenda | Georg Hess, MD, Wyeth is now a wholly owned subsidiary of Pfizer, Mundipharma Pte Ltd. | Follicular Lymphoma, Mantle Cell Lymphoma | 09/17 | 09/17 | | |
|
|
